ZA200804665B - Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt - Google Patents
Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium saltInfo
- Publication number
- ZA200804665B ZA200804665B ZA200804665A ZA200804665A ZA200804665B ZA 200804665 B ZA200804665 B ZA 200804665B ZA 200804665 A ZA200804665 A ZA 200804665A ZA 200804665 A ZA200804665 A ZA 200804665A ZA 200804665 B ZA200804665 B ZA 200804665B
- Authority
- ZA
- South Africa
- Prior art keywords
- fluorophenly
- pyrrol
- dihydroxy
- carbonyl
- isopropyl
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2964DE2005 | 2005-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200804665B true ZA200804665B (en) | 2009-07-29 |
Family
ID=40114304
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200804665A ZA200804665B (en) | 2005-11-08 | 2008-05-29 | Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt |
ZA200804664A ZA200804664B (en) | 2005-11-08 | 2008-05-29 | Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
ZA200804666A ZA200804666B (en) | 2005-11-08 | 2008-05-29 | Pharmaceutical combination |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200804664A ZA200804664B (en) | 2005-11-08 | 2008-05-29 | Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
ZA200804666A ZA200804666B (en) | 2005-11-08 | 2008-05-29 | Pharmaceutical combination |
Country Status (2)
Country | Link |
---|---|
CN (3) | CN101304968A (en) |
ZA (3) | ZA200804665B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102013157B1 (en) * | 2015-03-31 | 2019-08-23 | 대원제약주식회사 | Crystalline form and Method of preparing the same |
KR102218320B1 (en) * | 2019-07-12 | 2021-02-23 | 대원제약주식회사 | Method of preparing(3r,5r)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-((4-hydroxymethylphenylamino)carbonyl)-pyrrol-1-yl)-3,5-dihydroxy-heptanoic acid hemi calcium salt, and method of preparing intermediates used therein |
CN111494369B (en) * | 2020-05-27 | 2022-07-01 | 上海市第五人民医院 | Compound pharmaceutical composition for coronary heart disease |
CN113143916A (en) * | 2021-04-28 | 2021-07-23 | 苏州大学 | Application of Batimastat in preparation of medicine for preventing and treating obesity and secondary bone loss |
-
2006
- 2006-11-07 CN CNA2006800416190A patent/CN101304968A/en active Pending
- 2006-11-08 CN CNA2006800416148A patent/CN101304744A/en active Pending
- 2006-11-08 CN CN2006800416167A patent/CN101304967B/en not_active Expired - Fee Related
-
2008
- 2008-05-29 ZA ZA200804665A patent/ZA200804665B/en unknown
- 2008-05-29 ZA ZA200804664A patent/ZA200804664B/en unknown
- 2008-05-29 ZA ZA200804666A patent/ZA200804666B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101304967A (en) | 2008-11-12 |
ZA200804666B (en) | 2010-01-27 |
ZA200804664B (en) | 2009-04-29 |
CN101304968A (en) | 2008-11-12 |
CN101304744A (en) | 2008-11-12 |
CN101304967B (en) | 2011-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG166829A1 (en) | Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt | |
IL192242A0 (en) | Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides | |
SMT201400142B (en) | N- (1H-indazol-4-yl) immidazo [1,2-A] pyridin-3-carboxamide compounds substituted as cfms inhibitors | |
IL192241A0 (en) | Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof | |
ZA200806066B (en) | Process for the preparation of 6,6-dimethyl-3-azabicyclo[3.1.0]-hexane compounds and enantiomeric salts thereof | |
HK1115631A1 (en) | Process for the identification of novel enzyme interacting compounds | |
IL189589A0 (en) | Method for preparation of pharmaceutical composition having improved disintegratability | |
WO2007138282A3 (en) | Bi-aryl or aryl-heteroaryl substituted indoles | |
DE602005027388D1 (en) | MALONIC ACID AMID DERIVATIVES AS INHIBITORS OF G-SEKRETASE FOR THE TREATMENT OF ALZHEIMER DISEASE | |
EP2358691B8 (en) | Process for the preparation of piperazine compounds and hydrochloride salts thereof | |
IL184885A0 (en) | 7-{4-[2-(2,6-dihydro-4-methylphenoxy)ethoxyl]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-s-carboxylic acid cyclopropyl-(2,3-dimethylbenzyd amide as inhibitors of renin for the treatment of hypertension | |
ZA200804665B (en) | Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt | |
DE602006019710D1 (en) | MAGNESIUM SALT OF HMG COA REDUCTASE INHIBITORS | |
WO2005123670A3 (en) | Crystalline form of a substituted pyrrolidine compound | |
AP2007004270A0 (en) | Process for preparing salts of hydrocyanic acid | |
EP1984327A4 (en) | An improved process for the preparation of cilastatin and sodium salt | |
WO2007118873A3 (en) | Polymorphs of atorvastatin sodium and magnesium salts | |
DK2402306T3 (en) | Process for Preparation of 5-Aminolaevulinic Acid Hydrochloride | |
EP1883619A4 (en) | Process of preparation of substituted tetrafluorobenzylaniline compound and its pharmaceutically approved salts | |
WO2009097515A3 (en) | [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses | |
PT1829872E (en) | Processes for production of indole compounds | |
SI1891446T1 (en) | Process for the identification of novel enzyme interacting compounds | |
FR2894596B1 (en) | PROCESS FOR AUTOCALIBRATION OF BIOPUCES | |
WO2008010087A3 (en) | Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof | |
EP1971333A4 (en) | Amino acid derivatives of indolinone based protein kinase inhibitors |